Sign up to save your podcasts
Or
Share Episode 66 - Andy Parker - CEO of Step Pharma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 66 - Andy Parker - CEO of Step Pharma
Welcome to The BioHub podcast, where we interview the top minds from across the Biotech and Pharma industry.
Today I’m joined by Andy Parker, the CEO of Step Pharma.
Andy has spent over two decades in biotech and pharma,holding senior leadership roles at companies like AstraZeneca, Shire and Zealand Pharma and even spending time on the VC side at Eclosion.
Since 2019, he’s been leading Step Pharma, a companydeveloping first-in-class CTPS1 inhibitors, with their lead program now in the clinic for cancer.
We talk about the science behind Step’s approach, what’snext for the company, and Andy’s experience moving from big pharma to small biotech. Plus: lessons on fundraising in today’s market and building a great work culture.Enjoy and stay tuned.
View all episodes
By Max Brennan - Biotech HeadHunterWelcome to The BioHub podcast, where we interview the top minds from across the Biotech and Pharma industry.
Today I’m joined by Andy Parker, the CEO of Step Pharma.
Andy has spent over two decades in biotech and pharma,holding senior leadership roles at companies like AstraZeneca, Shire and Zealand Pharma and even spending time on the VC side at Eclosion.
Since 2019, he’s been leading Step Pharma, a companydeveloping first-in-class CTPS1 inhibitors, with their lead program now in the clinic for cancer.
We talk about the science behind Step’s approach, what’snext for the company, and Andy’s experience moving from big pharma to small biotech. Plus: lessons on fundraising in today’s market and building a great work culture.Enjoy and stay tuned.